Xencor XNCR
NASDAQ XNCR
$26.60 -0.02 (-0.06%)
As of: Sep 4, 2026 · 1:36 PM EDT

Xencor (XNCR) Interest Expenses (2013 - 2026)

Xencor (XNCR) posted quarterly Interest Expenses of $92.0 million for Q1 2026, up 962.15% year-over-year from $8.7 million in Q1 2025, and up 3617.08% quarter-over-quarter from $2.5 million in Q4 2025.

Analysis

Xencor (XNCR) Interest Expenses (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Interest Expenses for 14 consecutive years, with $92.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest Expenses rose 962.15% year-over-year to $92.0 million; the TTM figure through Mar 2026 stood at $92.0 million (up 369.4% YoY), while the FY2025 annual figure was $94.6 million, down 58.37% from the prior year.
  • Interest Expenses rose to $92.0 million in Q1 2026 per XNCR's latest filing, from $2.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $103.5 million in Q3 2024 and bottomed at -$2.6 million in Q4 2024.
  • Historically, Interest Expenses has averaged $33.1 million across 5 years, with a median of $9.7 million in 2024.
  • On a YoY basis, Interest Expenses climbed as much as 1236.46% in 2024 and fell as far as 167.64% in 2024.
  • Xencor's Interest Expenses stood at $2.9 million in 2022, then jumped by 36.97% to $3.9 million in 2023, then slumped by 167.64% to -$2.6 million in 2024, then surged by 193.58% to $2.5 million in 2025, then soared by 3617.08% to $92.0 million in 2026.
  • Business Quant data shows XNCR's Interest Expenses at $92.0 million in Q1 2026, $2.5 million in Q4 2025, and $97.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 139.31 Bn 131.46 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.65 Bn 77.66 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn -1.00 Mn
4 Moderna 57.94 Bn 52.80 Bn 52.00 Mn -
5 Revolution Medicines 44.05 Bn 44.05 Bn - 23.78 Mn
6 BeOne Medicines 39.96 Bn 34.86 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.16 Bn 31.85 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn - 93.62 Mn
9 Insmed 27.32 Bn 26.16 Bn 358.27 Mn 20.27 Mn
10 Xencor 2.02 Bn 1.64 Bn - 7.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.35 Mn
Mar 31, 2026 4.70 Mn
Dec 31, 2025 7.35 Mn
Sep 30, 2025 7.67 Mn
Jun 30, 2025 8.24 Mn
Mar 31, 2025 8.67 Mn
Dec 31, 2024 8.66 Mn
Sep 30, 2024 9.03 Mn
Jun 30, 2024 9.28 Mn
Mar 31, 2024 9.68 Mn
Dec 31, 2023 6.16 Mn
Sep 30, 2023 7,000.00
Jun 30, 2023 7,000.00
Mar 31, 2023 7,000.00
Jun 30, 2018 3,000.00
Mar 31, 2018 4,000.00
Dec 31, 2017 5,000.00
Sep 30, 2017 3,000.00
Jun 30, 2017 3,000.00
Mar 31, 2017 3,000.00